Senior Manager Benefit Risk Assessment operations at Bristol-Myers Squibb

Hyderabad, Telangana, India

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

  • PharmD/PhD or equivalent with a minimum of 5 years’ experience in Pharmacovigilance/Pharmaceutical Industry or equivalent
  • Thorough understanding of requirements for complex strategic documents and PBRER (Periodic Benefit-Risk Evaluation Report)
  • Strong experience in Clinical overview and Clinical documents - protocol, submission

Responsibilities

  • Attend meetings as part of structured benefit risk assessment (SBRA) to understand approaches and data, and contribute
  • Schedule meetings to discuss risk management strategy for upcoming authoring of risk management documents
  • Facilitate meetings with SBRA team, record and distribute meeting minutes, and follow up on action items
  • Produce a detailed timeline for Core SBRA document and ensure alignment with Clinical overview timelines
  • Perform project management to ensure timelines are met and follow up on deliverables
  • Author and edit sections for structured benefit risk assessment based on source documents like clinical study reports (e.g., investigator brochures)
  • Manage documents related to SBRA for review, adjudicate comments, and facilitate approvals
  • For various risk management documents (e.g., core additional risk minimization measures or regional), support authoring, formatting, coordination/project management compliant to BMS style guide and core template, outreach to stakeholders for review/approval, and dissemination to local markets
  • Support communications to local markets or key internal stakeholders on releases of risk management documents and rationale for updates
  • Understand relationships and dependencies between documents and ensure consistency in information (e.g., in IBs) and alignment of safety messaging across safety risk-related documents
  • Perform quality review of documents against source documents, ensure internal consistency and high quality
  • Ensure assigned documents are produced in accordance with relevant internal SOPs, BMS style guide, and core template
  • Contribute to and participate in internal audits as needed
  • Support other tasks as assigned

Skills

Benefit Risk Assessment
Structured Benefit Risk Assessment (SBRA)
Risk Management
Drug Safety
Regulatory Submissions
Meeting Facilitation
Document Authoring
Stakeholder Collaboration
Action Item Tracking

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI